Oryzon Genomics S.A.. (10/3/17). "Press Release: Significant Fact [Company Moves Registered Address from Barcelona to Madrid]". Madrid. |
2017-10-03 |
Oryzon Genomics S.A.. (10/26/18). "Press Release: Oryzon Raises EUR 13 Million through a Private Placement with US and European Investors [Not for US, CA, AU, JP, ZA or any other jurisdiction where unlawful]". Madrid & Cambridge, MA. |
2018-10-26 |
Orgenesis Inc.. (11/29/21). "Press Release: Orgenesis and Theracell Joint Venture to Receive up to €32 Million From Greek Government to Accelerate Rollout of POCare Centers and Deployment of OMPULs". Germantown, MD. |
2021-11-29 |
Orchard Therapeutics Ltd.. (3/27/19). "Press Release: Orchard Therapeutics Presents New Registrational Data Demonstrating Sustained Clinical Benefit of OTL-200 for the Treatment of MLD". Boston, MA & London. |
2019-03-27 |
Optimapharm d.d.. (7/21/20). "Press Release: Optimapharm Appoints Dr. Andrew Copestake as Chief Executive Officer". |
2020-07-21 |
Optimapharm d.d.. (2/6/19). "Press Release: Optimapharm Acquires Swiss Denothex and Becomes a Leading European Mid-size Clinical Research Organization". |
2019-02-06 |
Oniria Therapeutics, S.L.. (5/11/23). "Press Release: Oniria Therapeutics Closes €1.28 Million Seed Funding Round". Barcelona. |
2023-05-11 |
Oncgnostics GmbH. (4/16/18). "Press Release: Test for Uterine Cancer in Portugal. Biotech Firm Oncgnostics Grants Exclusive Licence for Cancer Screening Test". Lisbon & Jena. |
2018-04-16 |
Ona Therapeutics. (6/16/20). "Press Release: Ona Therapeutics Raises €30m in Series A Financing". Barcelona. |
2020-06-16 |
Ona Therapeutics. (12/2/21). "Press Release: Ona Therapeutics Appoints Dr Michel Detheux as Independent Chair to Board of Directors". Barcelona. |
2021-12-02 |
Nuage Therapeutics. (6/20/23). "Press Release: Nuage Therapeutics Raises €12M in Seed Financing Led by Sofinnova Partners and Asabys". Barcelona. |
2023-06-20 |
Nuage Therapeutics. (5/10/22). "Press Release: Nuage Therapeutics Appoints Biotech Entrepreneur and Executive Judit Anido as CEO". Barcelona. |
2022-05-10 |
Novartis AG. (7/20/23). "Press Release: Sandoz Announces Plans to Build a Biosimilar Technical Development Center in Slovenia to Support Future Growth of Biosimilar Pipeline". Basel. |
2023-07-20 |
Novartis AG. (10/21/21). "Press Release: Novartis Signs New Initial Agreement with BioNTech to Support Fill and Finish of the mRNA Pfizer-BioNTech COVID-19 vaccine". Basel. |
2021-10-21 |
NorthSea Therapeutics B.V.. (12/17/21). "Press Release: NorthSea Therapeutics Completes US$80 Million Series C Fundraising to Advance Clinical Programs in Metabolic Disorders". Amsterdam. |
2021-12-17 |
Nordic Nanovector ASA. (6/25/18). "Press Release: Nordic Nanovector Appoints Eduardo Bravo as Chief Executive Officer". Oslo. |
2018-06-25 |
NMS Group S.p.A.. (8/3/22). "Press Release: NMS Group S.p.A. Appoints Andrew Curtis as Chief Strategy Officer, Effective Immediately". |
2022-08-03 |
NMS Group S.p.A.. (8/1/22). "Press Release: Nerviano Medical Sciences S.r.l. Expands US Presence". |
2022-08-01 |
Newron Pharmaceuticals S.p.A.. (9/20/19). "Press Release: Newron Pharmaceutical Commercialization Partner Meiji Seika together with Eisai Announce the Approval of Safinamide for Parkinson’s Disease in Japan". Milan. |
2019-09-20 |
Newron Pharmaceuticals S.p.A.. (3/21/17). "Press Release: FDA Approves Xadago (safinamide) for Parkinson’s Disease (PD) Patients". Milan & Morristown, NJ. |
2017-03-21 |
Newron Pharmaceuticals S.p.A.. (3/2/17). "Press Release: Newron Announces 2016 Financial Results and Provides Outlook for 2017". Milan. |
2017-03-02 |
Newron Pharmaceuticals S.p.A.. (10/30/18). "Press Release: Investment Plan for Europe. EIB Backs Italian CNS Drug Developer Newron Pharmaceuticals with up to EUR 40m". Luxembourg & Milan. |
2018-10-30 |
NewAmsterdam Pharma B.V.. (6/28/22). "Press Release: NewAmsterdam Pharma and the Menarini Group Sign Licensing Deal to Commercialize Obicetrapib in Europe". Naarden, Miami, FL & Florence. |
2022-06-28 |
Nerre Therapeutics Ltd.. (7/7/21). "Press Release: Nerre Therapeutics Raises £20 Million in a Series B2 Financing Round". Stevenage. |
2021-07-07 |
Neovacs S.A.. (3/30/17). "Press Release: Neovacs Provides Corporate Update and Reports Full Year 2016 Financial Results". Paris. |
2017-03-30 |
Navigo Proteins GmbH. (9/6/23). "Press Release: Navigo Proteins and Nostrum Biodiscovery Announce a Research Collaboration to Enhance Affilin Ligand Discovery Using Cutting-edge AI and Molecular Modeling Techniques". Halle (Saale) & Barcelona. |
2023-09-06 |
Mologen AG. (8/1/18). "Press Release: Dr Ignacio Faus Appointed as New CEO of Mologen AG". Berlin. |
2018-08-01 |
MolMed S.p.A.. (9/11/18). "Press Release: MolMed Appoints Mr. Salvatore Calabrese Chief Financial Officer". Milan. |
2018-09-11 |
MolMed S.p.A.. (7/13/18). "Press Release: MolMed Signs a New, Three-year Agreement for the Development and Supply of Lentiviral Vectors. MolMed Will Provide GSK with Vectors for the Oncology Field". Milan. |
2018-07-13 |
MolMed S.p.A.. (4/14/20). "Press Release: MolMed: the Board of Directors, Based on the Scientific Evidence from the Experiments on Early-stage Pre-clinical Products, Decided to Suspend the Investments in These Projects". Milan. |
2020-04-14 |
MolMed S.p.A.. (3/9/20). "Press Release: The Board of Directors Approved the 2019 Full Year Financial Results". Milan. |
2020-03-09 |
MolMed S.p.A.. (3/7/19). "Press Release: MolMed and Genenta Science Confirm and Extend Their Partnership in the Oncology field". Milan. |
2019-03-07 |
MolMed S.p.A.. (3/6/20). "Press Release: MolMed Signs a Multi-year Agreement and Announces the Beginning of a New Collaboration in the Field of T Cell Therapies". Milan. |
2020-03-06 |
MolMed S.p.A.. (3/13/19). "Press Release: Partnership in the Field of Rare Genetic Diseases with Rocket Pharma Extended to Three New Therapeutic Indications". Milan. |
2019-03-13 |
MolMed S.p.A.. (2/7/17). "Press Release: MolMed and TTY Biopharm Entered into a Term Sheet to Commercialise Zalmoxis in certain Asian Territories". Milan. |
2017-02-07 |
MolMed S.p.A.. (2/27/17). "Press Release: MolMed and Rocket Pharma Establish a Collaboration Agreement in the Field of Gene Therapy for the Treatment of Fanconi Anemia". Milan. |
2017-02-27 |
MolMed S.p.A.. (12/18/19). "Press Release: Italy – the EIB Supports MolMed Investment in Research, Development and Manufacturing for Cancer and Rare Diseases Innovative Treatments". Oxford. |
2019-12-18 |
MolMed S.p.A.. (11/14/17). "Press Release: MolMed Completed the Fourth Tranche of the Share Capital Increase to Be Reserved to Société Générale Pursuant to “SEF – Standby Equity Facility” Agreement [Not for United States of America, Australia, Canada or |
2017-11-14 |
MolMed S.p.A.. (10/10/19). "Press Release: MolMed Informs on Its Decision to Withdraw the Conditional Marketing Authorization of Zalmoxis". Milan. |
2019-10-10 |
MolMed S.p.A. (at the request of AGC Inc.). (4/2/20). "Press Release: Offer Document Filed with Consob. Voluntary Public Tender Offer Launched by AGC Inc. on All the Ordinary Shares of MolMed S.p.A. [Not for release where violation of laws or regulations |
2020-04-02 |
Moderna, Inc.. (7/9/20). "Press Release: Moderna and ROVI Announce Collaboration for OUS Fill-Finish Manufacturing of Moderna’s COVID-19 Vaccine Candidate". Cambridge, MA & Madrid. |
2020-07-09 |
Moderna, Inc.. (1/4/21). "Press Release: Israeli Ministry of Health Authorizes COVID-19 Vaccine Moderna for Use in Israel". Cambridge, MA. |
2021-01-04 |
Minoryx Therapeutics S.L.. (9/5/18). "Press Release: Minoryx Therapeutics Announces Dosing of First US Patient in Phase 2/3 Clinical study of MIN-102 (ADVANCE)". Mataró, Barcelona. |
2018-09-05 |
Minoryx Therapeutics S.L.. (9/26/18). "Press Release: Minoryx Therapeutics Raises €21.3M in Series B Funding Round". Mataró, Barcelona. |
2018-09-26 |
Minoryx Therapeutics S.L.. (9/21/18). "Press Release: A Consortium Led by Minoryx Receives €0.8m to Explore Additional Indications for MIN-102". |
2018-09-21 |
Minoryx Therapeutics S.L.. (5/31/22). "Press Release: Minoryx Raises €51 Million to Support Marketing Authorization Application and Launch Preparations for X-linked Adrenoleukodystrophy (X-ALD) therapy". Mataró, Barcelona. |
2022-05-31 |
Minoryx Therapeutics S.L.. (3/12/19). "Press Release: Minoryx Therapeutics Appoints Didier Le Normand as Group Chief Financial Officer (CFO) and General Manager of Its Belgian Subsidiary". Mataró, Barcelona & Charleroi. |
2019-03-12 |
Minoryx Therapeutics S.L.. (2/8/17). "Press Release: Dr Claude Nicaise Joins Minoryx Therapeutics as Independent Board Member". Mataró, Barcelona. |
2017-02-08 |
Minoryx Therapeutics S.L.. (2/22/17). "Press Release: Minoryx Therapeutics Receives Orphan Drug Designation from the US FDA for Its Lead Candidate MIN-102". Mataró, Barcelona. |
2017-02-22 |
Minoryx Therapeutics S.L.. (2/20/18). "Press Release: Minoryx Therapeutics Spins Off SEE-Tx Platform into New Company, Gain Therapeutics". Mataró, Barcelona & Lugano. |
2018-02-20 |
Minoryx Therapeutics S.L.. (12/13/18). "Press Release: Minoryx Therapeutics Announces Early Completion of Patient Randomization in the ADVANCE Trial – a Phase 2/3 Clinical Study of MIN-102 in X-ALD Patients". Mataró, Barcelona. |
2018-12-13 |
Minoryx Therapeutics S.L.. (1/26/21). "Press Release: Minoryx Presents Topline Results from Phase 2/3 »ADVANCE« Study Demonstrating Significant Clinical Benefit of Leriglitazone in Adrenomyeloneuropathy (AMN)". Mataró, Barcelona. |
2021-01-26 |
Minoryx Therapeutics S.L.. (1/18/17). "Press Release: Minoryx Therapeutics Further Strengthens Its Scientific Advisory Board (SAB)". Mataró, Barcelona. |
2017-01-18 |
Mind the Byte S.L.. (7/10/17). "Press Release: Mind the Byte Raises 300,000 Euros in Its Second Equity Crowdfunding". |
2017-07-10 |
Mind the Byte S.L.. (5/9/17). "Press Release: Mind the Byte Launches a New Equity Crowdfunding Campaign with Crowdcube". |
2017-05-09 |
Mind the Byte S.L.. (11/15/17). "Press Release: Mind the Byte and Prosilico Sign a Strategic Partnership Agreement". |
2017-11-15 |
Mind the Byte S.L.. (1/11/18). "Press Release: Mind the Byte Acquires Intelligent Pharma". |
2018-01-11 |
Mestrelab Research S.L.. (3/21/18). "Press Release: Mestrelab Research Response to ACDLabs Press Release about Lawsuit for Copyright Infringement". |
2018-03-21 |
Merck KGaA. (9/21/22). "Press Release: Merck Enters Collaboration and Option to License Agreement with Nerviano Medical Sciences to Develop Next-Generation PARP1 Selective Inhibitor [ Not intended for US- or Canada- and UK-based media ]". Darmstadt. |
2022-09-21 |
Merck KGaA. (9/1/17). "Press Release: Heinrich Emanuel Merck Award for Analytical Science Goes to Professor Francesco Ricci". Darmstadt. |
2017-09-01 |
Merck KGaA. (8/31/17). "Press Release: Driving Innovation in Cancer Care at ESMO 2017 with New Data in Hard-to-Treat Cancers [Not intended for U.K. or U.S. based media]". Darmstadt. |
2017-08-31 |
Merck KGaA. (8/23/17). "Press Release: Merck Sets Up PMatX Incubator in Israel for Next-Generation Electronics". Darmstadt. |
2017-08-23 |
Merck KGaA. (7/8/21). "Press Release: Merck and Inbrain Neuroelectronics Collaborate to Develop the Next Generation of Bioelectronic Therapies". Darmstadt. |
2021-07-08 |
Merck KGaA. (2/9/17). "Press Release: Cladribine Tablets Significantly Reduced Brain Atrophy in Patients with Multiple Sclerosis". Darmstadt. |
2017-02-09 |
Merck KGaA. (10/3/17). "Press Release: Merck Invests € 35 Million in Its Italian Biotech Manufacturing Site of Bari". Bari. |
2017-10-03 |
MedLumics. (2/10/21). "Press Release: MedLumics Closes Upsized EUR 18M (21.7M USD) Financing Round and Appoints New Chairman". Madrid. |
2021-02-10 |
Medivir AB. (3/16/17). "Press Release: Medivir Completes Transition of Commercial Products to Fully Focus on Research and Development". Stockholm. |
2017-03-16 |
Medicen Paris Region. (5/23/17). "Press Release: French Tech Tour Healthcare Israel. Seven Start-ups Assess their Business Potential with Business France, Bpifrance and Medicen Paris Region". Paris. |
2017-05-23 |
MagForce AG. (12/15/20). "Press Release: MagForce AG Successfully Completes Private Placement of New Shares". Berlin & Nevada. |
2020-12-15 |
mAbxience S.L.. (2/13/17). "Press Release: mAbxience, European Success Accelerating Global Growth". |
2017-02-13 |
Lunaphore Technologies S.A.. (9/9/18). "Press Release: Menarini Will Bring Lunaphore’s Ultra-Rapid Tissue Staining Solution LabSat Frozen to Market". Lausanne & Florence. |
2018-09-09 |
Lunaphore Technologies S.A.. (5/24/18). "Press Release: Lunaphore and Vitro Sign Collaboration Agreement to Develop ISH Protocols for RNA/DNA Targets". Lausanne & Seville. |
2018-05-24 |
Lonza Group Ltd.. (9/8/20). "Press Release: Sheba Medical Center Treats First Patient with CAR-T Cell Immunotherapy Manufactured Using the Lonza Cell Immunotherapy Manufactured Using the Lonza Cocoon Platform". Basel & Tel Aviv. |
2020-09-08 |
Lonza Group AG. (5/16/17). "Press Release: Lonza Invests to Develop Exosomes for Next-generation Life Science Applications". Basel. |
2017-05-16 |
Lonza Group AG. (11/19/18). "Press Release: Lonza Opens Collaborative Innovation Center in Haifa, Israel". Haifa. |
2018-11-19 |
Lonza Group AG. (10/9/17). "Press Release: Lonza Announces Formation of New Research and Development Collaborative Innovation Center in Israel". Basel. |
2017-10-09 |
LogicBio Therapeutics, Inc.. (6/27/17). "Press Release: LogicBio Therapeutics Announces $50 Million in Financing to Develop Novel Gene Medicines for Pediatric Patients". Cambridge, MA. |
2017-06-27 |
Locust Walk Partners, LLC. (7/11/18). "Press Release: Locust Walk Appoints Lubor Gaal as Senior Vice President and Head of Europe to Further Advance Global Expansion of Transactions Business". London & Boston, MA. |
2018-07-11 |
LNC Therapeutics. (4/15/20). "Press Release: LNC Therapeutics Announces the Acquisition of an Exclusive Worldwide Licence on the First Patent related to Christensenella’s Therapeutic Applications in Mood Disorders". Bordeaux. |
2020-04-15 |
Lipopharma Therapeutics S.L.. (1/21/18). "Press Release: Lipopharma Awarded a 6.15m€ Grant by the H2020 Programme to Conduct a PIIb Trial with 2OHOA in Patients with Newly-diagnosed Glioblastoma". Palma de Mallorca & Acton, MA. |
2018-01-21 |
Life Biosciences LLC. (1/9/19). "Press Release: Senolytic Therapeutics Kicks Off Q1 2019 with High-profile Speaking Events Featuring Co-founders Marc Ramis and Manuel Serrano". Boston, MA. |
2019-01-09 |
LeanBio S.L.. (3/23/18). "Press Release: Syna Therapeutics, the New Joint Venture between LeanBio S.L. and Laboratoris Reig I Jofre". |
2018-03-23 |
Laboratoris Sanifit S.L.. (6/26/19). "Press Release: Sanifit Announces €72.2M ($80.9M) Financing in Spain’s Largest Private Biotech Fundraise". Palma & San Diego, CA. |
2019-06-26 |
Laboratoris Sanifit S.L.. (3/6/18). "Press Release: Sanifit Announces Results of the Phase II Clinical Trial of SNF472 in Patients with Calciphylaxis". Palma & San Diego, CA. |
2018-03-06 |
Laboratoris Sanifit S.L.. (1/8/18). "Press Release: Sanifit Announces the Appointment of Cris Calsada as Chief Financial Officer". Palma & San Diego, CA. |
2018-01-08 |
Kymos S.L.. (9/28/20). "Press Release: Kymos and Prolytic Merge to Become Kymos Group". Barcelona & Frankfurt a.M.. |
2020-09-28 |
KWS Saat SE & Co. KGaA. (3/10/21). "Press Release: KWS Acquires Tomato Breeding Company". Einbeck & Wageningen. |
2021-03-10 |
Kither Biotech S.r.l.. (7/5/19). "Press Release: Kither Biotech Raises a €5.6m Financing Round to Support the Clinical Development of a New Drug for Cystic Fibrosis and other Pulmonary Diseases". Turin. |
2019-07-05 |
Kiadis Pharma N.V.. (10/22/19). "Press Release: Kiadis Pharma Announces Formation of Renowned Scientific Advisory Board". Amsterdam. |
2019-10-22 |
Keensight Capital. (7/23/19). "Press Release: Keensight Capital Acquires 3P Biopharmaceuticals to Accelerate Its Global Growth Strategy". Paris. |
2019-07-23 |
Kaia Health Software GmbH. (11/30/20). "Press Release: Kaia Health and Chiesi Group Announce Strategic Partnership to Commercialise Kaia COPD Pulmonary Rehabilitation App in European Markets". Munich & Parma. |
2020-11-30 |
Izana Bioscience Ltd.. (4/6/20). "Press Release: Initiation of Two-centre Compassionate Use Study Involving Namilumab in the Treatment of Individual Patients with Rapidly Worsening COVID-19 Infection in Italy". Oxford. |
2020-04-06 |
Israel Advanced Technology Industries (IATI). (2/8/24). "Press Release: MIXiii Health-Tech.IL Annual Conference to Showcase Resilience and Growth of Israel's Life Sciences Industry Amid War". Herzliya. |
2024-02-08 |
IRB Barcelona. (5/21/19). "Press Release: The IRB Barcelona Spin-off Ona Therapeutics Hits the Road Thanks to Sabadell Asabys". |
2019-05-21 |
Iqvia. (4/30/18). "Press Release: Recordati Selects Iqvia’s OCE Technology Platform and OneKey Information Services". Danbury, CT & Research Triangle Park, NC. |
2018-04-30 |
Ipsen S.A.. (1/31/17). "Press Release: Ipsen to Acquire Primary Care Platform in Italy from Akkadeas Pharma". Paris. |
2017-01-31 |
Iproteos S.L.. (1/26/17). "Press Release: Grant of 700,000 € for the Discovery of Drugs against Atherosclerosis". |
2017-01-26 |
Iontas Ltd.. (5/13/20). "Press Release: FairJourney Biologics Joins Forces with Iontas to Create a Global Leader in Outsourced Antibody Discovery Services". Porto & Cambridge. |
2020-05-13 |
Ion Beam Applications S.A. (IBA). (12/8/22). "Press Release: IBA Wins 10 Proton Therapy System Contract in Spain". Louvain-la-Neuve. |
2022-12-08 |
Invivo Partners. (3/5/24). "Press Release: Invivo Partners Is Preparing to Launch a €100M Invivo Ventures III Fund to Invest in Leading-edge Life Sciences". Barcelona. |
2024-03-05 |